169 related articles for article (PubMed ID: 14569804)
1. A practical approach to the diagnosis of Hodgkin lymphoma.
Listinsky CM
Am J Clin Pathol; 2002 Jun; 117 Suppl():S76-94. PubMed ID: 14569804
[TBL] [Abstract][Full Text] [Related]
2. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
3. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
4. Lymphomas: membrane markers and cell flow cytometric diagnosis.
Glassman AB; Self S; Christopher J
Ann Clin Lab Sci; 1987; 17(1):1-7. PubMed ID: 3579204
[TBL] [Abstract][Full Text] [Related]
5. Pitfalls in diagnostic hematopathology -- Part II.
Zhao XF
Int J Clin Exp Pathol; 2009 Sep; 3(1):39-46. PubMed ID: 19918327
[TBL] [Abstract][Full Text] [Related]
6. Reed-Sternberg-Like Cells in Non-Hodgkin Lymphomas.
Gomez-Gelvez JC; Smith LB
Arch Pathol Lab Med; 2015 Oct; 139(10):1205-10. PubMed ID: 26414463
[TBL] [Abstract][Full Text] [Related]
7. New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma.
Zhang XM; Aguilera N
Arch Pathol Lab Med; 2014 Dec; 138(12):1666-72. PubMed ID: 25427044
[TBL] [Abstract][Full Text] [Related]
8. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
[TBL] [Abstract][Full Text] [Related]
10. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma.
Higgins RA; Blankenship JE; Kinney MC
Arch Pathol Lab Med; 2008 Mar; 132(3):441-61. PubMed ID: 18318586
[TBL] [Abstract][Full Text] [Related]
11. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.
Cho RJ; McCalmont TH; Ai WZ; Fox LP; Treseler P; Pincus LB
J Cutan Pathol; 2012 Jun; 39(6):651-8. PubMed ID: 22324490
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Profile of Hodgkin and Non-Hodgkin Lymphoma.
Shahid R; Gulzar R; Avesi L; Hassan S; Danish F; Mirza T
J Coll Physicians Surg Pak; 2016 Feb; 26(2):103-7. PubMed ID: 26876395
[TBL] [Abstract][Full Text] [Related]
13. Haematopathology practice: the commonest problems encountered in a consultation practice.
Isaacson PG
Histopathology; 2007 Jun; 50(7):821-34. PubMed ID: 17543071
[TBL] [Abstract][Full Text] [Related]
14. Bruton's tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma.
Fernández-Vega I; Quirós LM; Santos-Juanes J; Pane-Foix M; Marafioti T
Virchows Arch; 2015 Feb; 466(2):229-35. PubMed ID: 25433814
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System.
O'Malley DP; Fedoriw Y; Weiss LM
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):535-40. PubMed ID: 26447896
[TBL] [Abstract][Full Text] [Related]
16. [Borderline between Hodgkin and non-Hodgkin lymphomas with unfavorable clinical course: a clinical, histological and immunohistochemical analysis of 33 cases within the German Hodgkin Lymphoma Study].
Bernhards J; Fischer R; Werner M; Hübner K; Schwarze EW; Georgii A
Verh Dtsch Ges Pathol; 1992; 76():159-63. PubMed ID: 1283250
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Hodgkin lymphoma in the modern era.
Wang HW; Balakrishna JP; Pittaluga S; Jaffe ES
Br J Haematol; 2019 Jan; 184(1):45-59. PubMed ID: 30407610
[TBL] [Abstract][Full Text] [Related]
18. Studies on the use of membrane markers for the differential diagnosis of malignant lymphomas.
Holowiecki J; Lutz D; Baumgartner G; Hanak H; Knapp W
Oncology; 1979; 36(3):139-43. PubMed ID: 314078
[TBL] [Abstract][Full Text] [Related]
19. Practical approach to the immunodiagnosis of lymphomas emphasizing differential diagnosis.
Warnke RA; Weiss LM
Cancer Surv; 1985; 4(2):349-58. PubMed ID: 3879857
[TBL] [Abstract][Full Text] [Related]
20. Validation of CD137 Immunohistochemical Stain on Paraffin-Embedded Tissue as a Marker to Facilitate Distinction Between Classic Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma, T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, and Anaplastic Large Cell Lymphoma.
Carbone PN; Zhang QY
Arch Pathol Lab Med; 2019 Mar; 143(3):280-281. PubMed ID: 30816829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
